Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.

Nearly a year after alarms about CAR T-cell therapies possibly causing secondary lymphomas, studies suggest that genetic predisposition—not vector integration—are likely the primary cause of these ...

As we celebrate the third anniversary of Cancer Research Communications (CRC), we reflect on the remarkable journey we have undertaken since assuming the roles of co-Editors-in-Chief. Our mission from ...

Department of Oncology, VIB-KU Leuven Center for Cancer Biology, and KU Leuven, Leuven, Belgium.

Department of Medicine III – Hematology/Oncology, LMU University Hospital, LMU Munich, Munich, Germany.

College of Pharmacy, Vessel-Organ Interaction Research Center (VOICE, MRC), Kyungpook National University, Daegu, Republic of Korea.

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. *Corresponding Author: Marc Ladanyi, Department of Pathology and Laboratory Medicine, Memorial ...

Department of Colorectal Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...

M. Piffoux and J. Jacquemin contributed equally to this article. O. Tredan and Y. Drouet contributed equally to this article.

Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan. *Corresponding Author: Max S. Wicha, Department of Internal Medicine, University of Michigan–Ann Arbor, 2800 Plymouth Road ...

Department of Medical Oncology, Center for Cancer Immunotherapy, Institut Curie, Paris, France. *Corresponding Author: Emanuela Romano, Department of Medical Oncology, Center for Cancer Immunotherapy, ...